600380.SS SHH
Joincare Pharmaceutical Group Industry Co.,Ltd.
1W: +8.3%
1M: +10.3%
3M: +2.9%
YTD: -13.2%
1Y: -17.1%
3Y: -13.9%
5Y: -20.1%
¥10.16 ($1.52)
+0.26 (+2.63%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$15.6B
-6.2% ▼
5Y CAGR: +5.4%
Gross Profit
$9.5B
-5.2% ▼
5Y CAGR: +4.4%
Operating Income
$3.6B
+3.1% ▲
5Y CAGR: +10.6%
Net Income
$1.4B
-3.9% ▼
5Y CAGR: +9.2%
EPS (Diluted)
$0.74
-2.6% ▼
5Y CAGR: +9.9%
EBITDA
$3.9B
+0.7% ▲
5Y CAGR: +10.8%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $13.5B | $15.9B | $17.1B | $16.6B | $15.6B |
| YoY Growth | +12.9% | +17.6% | +7.8% | -2.9% | -6.2% |
| Cost of Revenue | $4.9B | $5.8B | $6.4B | $6.6B | $6.1B |
| Gross Profit | $8.6B | $10.1B | $10.8B | $10.0B | $9.5B |
| Gross Margin | 63.4% | 63.7% | 62.8% | 60.3% | 61.0% |
| R&D Expenses | $1.1B | $1.4B | $1.7B | $1.7B | $1.4B |
| SG&A Expenses | $4.9B | $6.0B | $5.9B | $5.4B | $4.8B |
| Operating Expenses | $5.6B | $7.1B | $7.3B | $6.5B | $5.9B |
| Operating Income | $3.0B | $3.0B | $3.5B | $3.5B | $3.6B |
| Operating Margin | 22.0% | 18.8% | 20.3% | 21.1% | 23.2% |
| Interest Expense | $42M | $96M | $147M | $155M | $138M |
| Income Before Tax | $3.0B | $3.0B | $3.5B | $3.5B | $3.6B |
| Tax Expense | $372M | $339M | $562M | $615M | $592M |
| Net Income | $1.1B | $1.3B | $1.5B | $1.4B | $1.4B |
| Net Margin | 8.3% | 8.4% | 8.8% | 8.7% | 8.9% |
| EPS (Diluted) | $0.57 | $0.69 | $0.79 | $0.76 | $0.74 |
| EBITDA | $3.0B | $3.2B | $3.7B | $3.8B | $3.9B |
| Shares Outstanding | 1.96B | 1.94B | 1.90B | 1.90B | 1.87B |